Intermediate and High-risk Luminal and Triple Negative Breast Cancer
1 clinical trials · Condition
◉ Watch Intermediate and High-risk Luminal and Triple Negative Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Comparing Sequential Neoadjuvant Treatment Including Chemotherapy and Accelerated Radiation Focused to the Tumor Bed vs Neoadjuvant Chemotherapy Alone (NCT02806258) | University Hospital, Grenoble | 2016-04-26 |
Track Intermediate and High-risk Luminal and Triple Negative Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.